Salta alla navigazione principale Salta alla ricerca Salta al contenuto principale

Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey

  • Giovanni D'Arena
  • , Luca Laurenti
  • , Marta Coscia
  • , Agostino Cortelezzi
  • , Annalisa Chiarenza
  • , Gabriele Pozzato
  • , Maria Luigia Vigliotti
  • , Giuseppe Nunziata
  • , Alberto Fragasso
  • , Maria Rosaria Villa
  • , Alberto Grossi
  • , Carmine Selleri
  • , Silvia Deaglio
  • , Antonio La Sala
  • , Giovanni Del Poeta
  • , Vittorio Simeon
  • , Luig Aliberti
  • , Laura De Martino
  • , Aldo Giudice
  • , Pellegrino Musto
  • Vincenzo De Feo
  • IRCCS Centro di riferimento oncologico della Basilicata - Rionero in Vulture (PZ)
  • University of Turin
  • University of Milan
  • University of Catania
  • University of Trieste
  • AORN S. Anna e S. Sebastiano
  • Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli
  • Madonna delle Grazie Hospital
  • Ospedale S. Gennaro
  • Hematology Unit, IFCA
  • University Hospital ‘San Giovanni di Dio e Ruggi d’Aragona’
  • IRCCS Ospedale Casa Sollievo della Sofferenza - San Giovanni Rotondo (FG)
  • University of Rome Tor Vergata
  • University of Salerno
  • IRCCS Istituto nazionale tumori Fondazione Giovanni Pascale - Napoli

Risultato della ricerca: Contributo in rivistaArticolo

Abstract

Complementary and alternative medicine (CAM) is common in patients with cancer and its use is steadily increasing over time. We performed a multicenter survey in which the use of CAM in 442 Italian patients with chronic lymphocytic leukemia (CLL), the commonest form of leukemia in Western countries, was assessed. Data were collected by means of a face-to-face standardized questionnaire with several items. Mean age was 69 years; 258 patients (58%) were male and 184 (42%) female. Seventy-three patients (16.5%) were found to be CAM users. The most common CAM therapies were green tea, aloe formulations and high dose vitamins. Predictors of CAM use were female gender, younger age, higher education level, internet availability and newspaper reading. The reasons for CAM popularity among these patients are complex. Given the number of patients combining therapy with CAM and its possible drug interactions, doctor interest as well as patient education about CAM should be improved.
Lingua originaleInglese
pagine (da-a)841-847
Numero di pagine7
RivistaLEUKEMIA & LYMPHOMA
DOI
Stato di pubblicazionePubblicato - 2014

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

  1. SDG 3 - Salute e benessere
    SDG 3 Salute e benessere

Keywords

  • CLL

Fingerprint

Entra nei temi di ricerca di 'Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey'. Insieme formano una fingerprint unica.

Cita questo